Concepedia

Nadim Akhtar

NA

Statistics

Publications

5

Citations

216

H-Index

5

Active since

2017

Affiliations

AstraZeneca (United Kingdom)(Current)

AstraZeneca (Singapore)

Roche (Switzerland)

GlaxoSmithKline (United Kingdom)

Ionis Pharmaceuticals (United States)

Nadim Akhtar is an author at AstraZeneca (United Kingdom) specializing in pharmacy, pharmaceutics, and oligonucleotide chemistry.

Publications per year

2017–2022

5

Publications

5

Impurities in Oligonucleotide Drug Substances and Drug Products

Daniel C. Capaldi, Andy Teasdale, Scott P. Henry et al. · Nucleic Acid Therapeutics · 2017 · 130 citations

, , +15

Highway to Success—Developing Advanced Polymer Therapeutics

Marianne Ashford, R. England, Nadim Akhtar · Advanced Therapeutics · 2021 · 31 citations · Full text

, , +15

Evaluation of Particle Size Techniques to Support the Development of Manufacturing Scale Nanoparticles for Application in Pharmaceuticals

Stephen Wren, Caterina Minelli, Yiwen Pei et al. · Journal of Pharmaceutical Sciences · 2020 · 20 citations

, , +14

Determination of Purge Factors for Use in Oligonucleotide Control Strategies

Yannick Fillon, Nadim Akhtar, Benjamin I. Andrews et al. · Organic Process Research & Development · 2022 · 18 citations · Full text

, , +17

Strategies for Identity Testing of Therapeutic Oligonucleotide Drug Substances and Drug Products

Daniel C. Capaldi, Nadim Akhtar, Tom Atherton et al. · Nucleic Acid Therapeutics · 2020 · 17 citations

, , +15

1–5 of 5